Balyasny Asset Management LLC Rx Sight, Inc. Transaction History
Balyasny Asset Management LLC
- $63.6 Billion
- Q4 2024
A detailed history of Balyasny Asset Management LLC transactions in Rx Sight, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 23,978 shares of RXST stock, worth $714,784. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,978Holding current value
$714,784% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RXST
# of Institutions
222Shares Held
33.4MCall Options Held
531KPut Options Held
50.1K-
Ra Capital Management, L.P. Boston, MA3.74MShares$112 Million2.08% of portfolio
-
Black Rock Inc. New York, NY2.4MShares$71.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.38MShares$71.1 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC2.16MShares$64.4 Million0.01% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.55MShares$46.3 Million0.09% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $824M
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...